ask="N/A"
ask_size="N/A"
average_daily_volume="205944"
bid="3.42"
bid_size="600"
book_value="0.56"
change="+0.02"
change_from_200_day_moving_average="1.51"
change_from_50_day_moving_average="0.53"
change_from_52_week_high="-0.46"
change_From_52_week_low="2.18"
change_in_percent="+0.47%"
close="4.24"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.58"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="4.26"
high_52_weeks="4.70"
last_trade_date="3/17/2017"
last_trade_price="4.24"
last_trade_size="12043"
last_trade_time="4:00pm"
low="4.11"
low_52_weeks="2.06"
market_capitalization="79.23M"
moving_average_200_day="2.73"
moving_average_50_day="3.71"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="4.25"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+55.22%"
percent_change_from_50_day_moving_average="+14.19%"
percent_change_from_52_week_high="-9.79%"
percent_change_from_52_week_low="+105.82%"
previous_close="4.22"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.50"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="3.19"
stock_exchange="NCM"
symbol="BCLI"
volume="63225"
weeks_range_52="2.06 - 4.70"
